Griffith University

Contact details for Professor Susan Hurley

Biography    

Professor Hurley trained as a Pharmacist and then completed a Masters degree in Pharmacokinetics and a PhD at Monash University in Health Economics and Epidemiology.  She was awarded a National Health Medical and Research Council Neil Hamilton Fairley Fellowship in 1992 and studied at the University of Washington in Seattle, completing a Masters degree in Biostatistics.

Susan has worked in both academia and the pharmaceutical industry and currently runs her own company, Bainbridge Consultants.  Her research and consulting work is focused on analysis of the cost-effectiveness of health care.

Research interest

• Analysis of the Cost-effectiveness of Health Care

Publications

Refereed journal articles

• Hurley SF, Matthews JP, Guymer RH. (2008) Cost-Effectiveness of Smoking Cessation to Prevent Age-Related Macular Degeneration.Cost effectiveness Analysis and Resource Allocation. 6:18.
• Hurley SF, Matthews JP. (2008) The cost-effectiveness of the Australian National Tobacco Campaign. Tobacco Control.
• Hurley SF, Matthews JP, Guymer RH. (2008) Cost-Effectiveness of Ranibizumab for Neovascular Age-Related Macular Degeneration. Cost effectiveness Analysis and Resource Allocation.6:12.
• Hurley SF, Matthews JP. (2007) The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost-Effectiveness Analysis and Resource Allocation. 5:2.
• Hurley SF. (2005) Short-term impact of smoking cessation on myocardial infarction and stroke hospitalisations and costs in Australia. Medical Journal of Australia. 183:13-17.
• Pirotta M, Gunn J, Chondros P, Grover S, O’Malley P, Hurley S, Garland S. (2004) Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: A randomised controlled trial. British Medical Journal. 329:548.
• Pirotta M, Gunn J, Chondros P, Grover S, Hurley S, Garland S. (2004) The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised trial [ISRCTN24141277] BMC Family Practice. 5:5.
• Hurley SF, Scollo MM, Younie SJ, English DR, Swanson MG. (2004) The potential for tobacco control to reduce PBS drug costs for smoking-related cardiovascular disease. Medical Journal of Australia. 181 (5): 252-255.
• Kermode M, Young K, Hurley S, Marmion B. (2003) An economic evaluation of increased uptake in Q fever vaccination amongst meat and agricultural industry workers following implementation of the National Q Fever Management Program. Australian Journal of Public Health. 27:390-398.
• Hurley SF, Bennet J, Gust I. (1998) Issues about pertussis vaccines [letter]. Lancet. 351:678.
• Cicuttini FM, Hurley SF, McNeil JJ, Forbes A, Donnan GA, Salzberg M, Giles GG. (1997) Association of adult glioma with medical conditions, family and reproductive history. International Journal of Cancer. 71:203-207.
• Hurley SF, Jolley DJ, Kaldor JM. (1997) The effectiveness of needle exchange programs for prevention of human immunodeficiency virus infection. Lancet. 349:1797-1800.
• Hurley SF, Kaldor JM, Gardiner S, Carlin JB, AssunHno RM, Evans DB. (1996) Lifetime cost of human immunodeficiency virus-related health care. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12:371-378.
• Hurley SF, McNeil JJ, Donnan GA, Forbes A, Salzberg M, Giles GG. (1996) Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. Journal of Epidemiology and Community Health. 50:442-446.
• Law MG, Hurley SF, Carlin JB, Chondros P, Gardiner S, Kaldor JM. (1996) A comparison of patient interview data with pharmacy and medical records for patients with AIDS or HIV infection. Journal of Clinical Epidemiology. 49:997-1002.
• Carlin JB, Langdon P, Hurley SF, Ziegler JB, Doherty R, Chondros P, Kaldor JM. (1996) Health care and its costs for children with perinatally acquired HIV infection. Journal of Paediatrics and Child Health. 32:42-47.
• Hurley SF, Bond LM, Carlin JB, Evans DB, Kaldor JM. (1995) A method for estimating baseline health care costs. Journal of Epidemiology and Community Health. 49:525-531.
• Hurley SF, Kaldor JM, Carlin JB, Gardiner S, Evans DB, Chondros P, Hoy J, Spelman D, Spicer WJ, Wraight H,
• Meese P. (1995) The usage and costs of health services for HIV infection in Australia. AIDS. 9:777-785.
• Evans DB, Hurley SF. (1995) The application of economic evaluation techniques in the health sector: the state of the art. Journal of International Development. 7:503-524.
• Giles GG, McNeil JJ, Donnan G, Webley C, Staples MP, Ireland PD, Hurley SF, Salzberg M. (1994) Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. International Journal of Cancer. 59:357-362.
• Hurley SF, Huggins RM, Jolley DJ, Reading D. (1994) Recruitment activities and sociodemographic factors that predict attendance at a mammographic screening program. American Journal of Public Health. 84:1655-1658.
• Hurley SF, Livingston PM, Thane N, Quang L. (1994) Mammographic screening: measurement of cost in a population-based programme in Victoria, Australia. Journal of Epidemiology and Community Health. 48:391-399.
• Cockburn J, Staples M, Hurley SF, De Luise T. (1994) The psychological consequences of screening mammography. Journal of Medical Screening. 1:7-12.
• You RX, McNeil JJ, Hurley SF, Farish SJ, O’Malley HM, Quang L, Donnan GA. (1993) Smoking as a risk factor for cortical ischaemia presumably due to carotid occlusive disease. Neuroepidemiology. 12:141-147.
• Ryan P, Hurley SF, Johnson AM, Salzberg M, Lee MW, North JB, McNeil JJ, McMichael AJ. (1993) Tumours of the brain and possession of antibodies to Toxoplasma gondii: results from two Australian case-control studies. International Journal of Epidemiology. 22:412-419.
• Donnan GA, O’Malley HM, Quang L, Hurley S, Bladin PF. (1993) The capsular warning syndrome: pathogenesis and clinical features. Neurology. 43:957-962. The Essendon Breast X-Ray Program Collaborative Group (inc SF Hurley). (1992) A mammographic screening pilot project in Victoria 1988-1990. Medical Journal of Australia. 157:670-673.
• Hurley SF, Kaldor JM. (1992) The benefits and risks of mammographic screening for breast cancer. Epidemiologic Reviews. 14:101-130.
• Cockburn J, De Luise T, Hurley S, Clover K. (1992) Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Social Science in Medicine. 34:1129-1134.
• Hurley SF. (1992) Indices of therapeutic outcome for pharmacoeconomic evaluation of drug therapy [leading article]. Pharmacoeconomics. 1:155-160
• Hurley SF, Huggins RM, Snyder RD, Bishop JF. (1992) The cost of breast cancer recurrences. British Journal of Cancer. 65:449-455.
• Hurley SF, Jolley DJ, Livingston PM, Reading D, Cockburn J. Flint-Richter D. (1992) Effectiveness, costs and cost-effectiveness of recruitment strategies for a mammographic screening program to detect breast cancer. Journal of the National Cancer Institute. 84:855-863.
• Hurley SF, McNeil JJ, Jolley DJ, Harvey R. (1992) Linking prescription and patient-identifying data: a pilot study. Medical Journal of Australia. 156:383-386.
• Hurley SF, Livingston PM. (1991) Personal costs incurred by women attending a mammographic screening programme. Medical Journal of Australia. 154:132-134.
• Hurley SF. (1990) A review of cost-effectiveness analyses. Medical Journal of Australia. 153[suppl]:S20-S23.
• Hurley SF, Williams SL, McNeil JJ. (1990) Trends in prescribing of antihypertensive drugs in Australia, 1977-1987. Medical Journal of Australia. 152: 263-6.
• Hurley SF, Livingston PM, Jolley DJ, Hart S. (1990) Patterns of surgical treatment of breast cancer in Victoria. Australian New Zealand Journal of Surgery. 60:871-878.
• Hurley SF. (1990) Screening: the need for a population register [leading article]. Medical Journal of Australia. 153:310-311.
• Jenkins MA, Hurley SF, Bowes G, McNeil JJ. (1990) Use of anti-asthmatic drugs in Australia. Medical Journal of Australia. 153:323-328.

Non-refereed journal article

• Hurley S. (1991) Breast cancer: epidemiology, aetiology and strategies for control. Cancer Forum. 15:22-24.

Invited conference presentations

• Hurley SF and Matthews J. (2005) The Quit Benefits Model: a model to assess the cost-effectiveness of tobacco control programs. Third Australian Tobacco Control Conference, November.
• Hurley SF. (2003) The potential for tobacco control to reduce cost pressures on the PBS. Second Australian Tobacco Control Conference, Melbourne, April.
• Hurley SF. (2002) CSL Vaccines. Past, present and future. Industry Forum, Public Health Association Immunisation Conference, Melbourne, May.
• Hurley SF. (1999) Future vaccine business opportunities. Macquarie Bank Pharmaceutical Industry Seminar, Sydney.
• Hurley SF. (1997) Health service utilisation data for estimating costs. DIA Conference, Cairns, September.
• Hurley SF. (1991) Overview: Screening in medicine - for better, for worse? Women in Medical Science Seminar, Melbourne, July.
• Hurley SF. (1990) The cost-effectiveness of recruitment strategies for mammographic screening. National Cancer Institute Seminar. Washington D.C., November.
• Hurley SF. (1990) Personal recruitment to mammographic screening programs. Australian Cancer Society conference on recruitment strategies for mammographic screening, Melbourne, May.

Other published articles

• Hurley SF. (2006) Hospitalisations and costs attributable to tobacco smoking in Australia: 2001-2002 [letter]. Medical Journal of Australia. 184: 45.
• Hurley SF, Cockburn J, Livingston PM, Reading D. (1993) The acceptability of personal invitations to a mammographic screening program [letter]. Medical Journal of Australia. 158:792.
• Hurley SF. (1990) Counting the costs of mammographic screening: first year results of the Sydney study [letter]. Medical Journal of Australia. 53:174-175.
• Cockburn J, De Luise T, Hill D, Hurley S, Reading D, Russell I. (1990) General practitioner referrals to the Essendon Breast X-ray Program [letter]. Medical Journal of Australia. 152:332.